• LAST PRICE
    0.2500
  • TODAY'S CHANGE (%)
    Trending Down-0.0069 (-2.6859%)
  • Bid / Lots
    0.2500/ 11
  • Ask / Lots
    0.2501/ 4
  • Open / Previous Close
    0.2569 / 0.2569
  • Day Range
    Low 0.2500
    High 0.2585
  • 52 Week Range
    Low 0.1500
    High 1.8100
  • Volume
    232,847
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.2569
TimeVolumeBGXX
09:32 ET16700.2571
09:34 ET478860.2571
09:36 ET50000.256001
09:38 ET9360.2585
09:39 ET184800.258399
09:41 ET154630.256
09:43 ET10780.2585
09:45 ET46370.2585
09:50 ET4200.2559
09:52 ET19620.257899
09:54 ET3000.258
09:57 ET2000.256
09:59 ET13000.2569
10:01 ET226880.258
10:03 ET25340.258
10:06 ET44610.258
10:08 ET4000.2501
10:10 ET65000.2501
10:12 ET16000.258
10:14 ET12820.254685
10:15 ET114170.252399
10:21 ET10000.2513
10:24 ET362590.25
10:26 ET2470.25
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBGXX
Bright Green Corp
47.9M
-4.6x
---
United StatesEYEN
Eyenovia Inc
46.7M
-1.5x
---
United StatesODTC
Odonate Inc
49.6M
-1,247.4x
---
United StatesLEXX
Lexaria Bioscience Corp
47.0M
-4.5x
---
United StatesVYNE
Vyne Therapeutics Inc
41.7M
-0.5x
---
United StatesAPM
Aptorum Group Ltd
45.1M
-2.5x
---
As of 2024-03-28

Company Information

Bright Green Corporation is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured in exact formulations for research and pharmaceutical applications and as an active ingredient to consumer-based solutions. The Company is engaged in cannabis propagation, cultivation, and manufacturing of cannabis products, including cannabis flower, pre-rolls, concentrates, vape pens, capsules, tinctures, edibles, topicals and any other cannabis-related products requested for authorized sales. The Company plans to sell extracted oils from medicinal plants grown in these high-tech facilities and processed onsite through a system that vertically integrates the genetically altered growth of the plants to conform to automated growing systems. It also plans to cultivate and manufacture cannabis for federally sanctioned research, as well as perform authorized research on cannabis, including cannabinol (CBN), cannabigerol (CBG), and cannabidiol (CBD).

Contact Information

Headquarters
401 East Las Olas Blvd., Suite 1400FT LAUDERDALE, FL, United States 33301
Phone
201-370-1140
Fax
302-636-5454

Executives

Chairman of the Board
Lynn Stockwell
Chief Executive Officer, Director
Gurvinder Singh
Chief Financial Officer
Saleem Elmasri
Lead Independent Director
Dean Valore
Director
Sean Deson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$47.9M
Revenue (TTM)
$0.00
Shares Outstanding
186.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.05
Book Value
$0.07
P/E Ratio
-4.6x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.